Ophthalmic products

42


Ophthalmic products





Introduction


The human eye is a remarkable organ and the ability to see is one of our most treasured possessions. Thus, the highest standards are necessary in the compounding of ophthalmic preparations and the greatest care is required in their use. It is necessary that all ophthalmic preparations are sterile and essentially free from foreign particles.


These preparations may be categorized as follows:



Medicaments contained in ophthalmic products include:




Anatomy and physiology of the eye


Figure 42.1 gives an indication of the relevance of the external structures of the eye and the structure of the eyelids to the application of medication and the wearing of contact lenses (see p.406 also).




Formulation of eye drops


The components of an eye drop formulation are given below:



The single most important requirement of eye drops is that they are sterile. Historically, instances of microbially contaminated eye drops have been reported; the contaminating organism, Pseudomonas aeruginosa, is difficult to treat successfully and can cause loss of the eye.



Antimicrobial preservatives


Multiple-dose eye drops contain an effective antimicrobial preservative system, which is capable of withstanding the test for efficacy of antimicrobial preservatives of the British Pharmacopoeia (BP 2007). This ensures that the eye drops are maintained sterile during use and will not introduce contamination into the eyes being treated. Normal healthy eyes are quite efficient at preventing penetration by microorganisms. Eyes that have damaged epithelia are compromised and may be colonized by microorganisms. This has to be guarded against. The lack of vascularity of the cornea and certain internal structures of the eye make it very susceptible and difficult to treat once infection has been established.


No single substance is entirely satisfactory for use as a preservative for ophthalmic solutions. The systems that have been used, based on work of the author and others in the 1960s, have formed the basis of effective preservation over the subsequent years.


Eye drops specifically formulated for use during intraocular surgery should not contain a preservative because of the risk of damage to the internal surfaces of the eye. Diagnostic dyes should preferably be supplied as single-dose preparations. Preservatives which are suitable for a selection of eye drops are given in Box 42.1.





Benzalkonium chloride


This quaternary ammonium compound is the preservative of choice. It is in over 70% of commercially produced eye drops and over a third of these also contain disodium edetate, usually at 0.1% w/v.


Benzalkonium chloride is not a pure material, but is a mixture of alkylbenzyldimethyl ammonium compounds. This permits a mixture of alkyl chain lengths containing even numbers of carbon atoms between 8 and 18 and results in products of different activities. The longer the carbon chain length, the greater the antibacterial activity but the less the solubility. Therefore the manufacturer should seek to maximize the activity within the constraints of solubility. This means maximizing the proportions of C12, C14 and C16. It should be noted that Benzalkonium Chloride BP contains 50% w/v benzalkonium chloride.


Benzalkonium chloride is well tolerated on the eye up to concentrations of 0.02% w/v but is usually used at 0.01% w/v. It is stable to sterilization by autoclaving. The compound has a rapid bactericidal action in clean conditions against a wide range of Gram-positive and Gram-negative organisms. It destroys the external structures of the cell (cell envelope). It is active in the controlled aqueous environment and pH values of ophthalmic solutions. Activity is reduced in the presence of multivalent cations (Mg2+, Ca2+). These compete with the antibacterial for negatively charged sites on the bacterial cell surface. It also has its activity reduced if heated with methylcellulose or formulated with anionic and certain concentrations of non-ionic surfactants. Benzalkonium chloride is incompatible with fluorescein (large anion) and nitrates and is sorbed from solutions through contact with rubber.


The antibacterial activity of benzalkonium is enhanced by aromatic alcohols (benzyl alcohol, 2-phenylethanol and 3-phenylpropanol) and its activity against Gram-negative organisms is greatly enhanced by chelating agents such as disodium edetate. These agents chelate the divalent cations, principally Mg2+, of Gram-negative cells. These ions form bridges and bind the polysaccharide chains which protrude from the outer membrane of these cells. Thus, the integrity of the membrane is compromised and the benzalkonium chloride activity enhanced. This is particularly valuable in preserving against contamination with Pseudomonas aeruginosa.


The surface activity of benzalkonium chloride may be used to enhance the transcorneal passage of non-lipid-soluble drugs such as carbachol. Care must be taken since the preservative can solubilize the outer oily protective layer of the precorneal film. This film has an internal mucin layer in contact with the corneal and scleral epithelia, a middle aqueous layer and an outer oily layer. The oil prevents excessive aqueous evaporation and protects the inner surface of the lids from constant contact with water. The blink reflex helps maintain the integrity of the precorneal film. For these reasons, it is important not to use benzalkonium chloride to preserve local anaesthetic eye drops which abolish the blink reflex. The combined effect of the two agents causes drying of the eye surface and irritation of the cornea.







Viscosity enhancers


There is a general assumption that increasing the viscosity of an eye drop increases the residence time of the drop in the eye and results in increased penetration and therapeutic action of the drug. Most commercial preparations have their viscosities adjusted to be within the range 15–25 millipascal seconds (mPas). However, gently pressing downwards on the inside corner of the closed eye restricts the drainage channel into the nasal cavity and prolongs contact time. This has been recommended to increase the therapeutic index of antiglaucoma medications. Under normal conditions, a large proportion of a typical 50 μL drop will have drained from the conjunctival sac (capacity 25 μL) within 30 s. There will be no trace of the drop after 20 min.





pH adjustment


The best compromise is required after considering the following factors:



Most active ingredients are salts of weak bases and are most stable at an acid pH but most active at a slightly alkaline pH.


The lachrymal fluid has a pH of 7.2–7.4 and also possesses considerable buffering capacity. Thus a 50 μL eye drop which is weakly buffered will be rapidly neutralized by lachrymal fluid. Where it is possible, very acidic solutions, such as adrenaline acid tartrate or pilocarpine hydrochloride, are buffered to reduce a stinging effect on instillation. Suitable buffers are shown in Box 42.2.






Bioavailability


The effect of pH on the therapeutic activity of weak bases such as atropine sulphate has already been indicated under the section on pH adjustment. At acid pH, these bases exist in the ionized hydrophilic form. In order to penetrate the cornea, the bases need to be at alkaline pH so that they are in the unionized lipophilic form. Thus at tear pH (7.4) they are able to penetrate the outer lipid layer of the lipid–water–lipid sandwich, which constitutes the physicochemical structure of the cornea. Once inside the epithelium the undissociated free base will partially dissociate. The water-soluble dissociated moiety will then traverse the middle aqueous stromal layer of the cornea. When the dissociated drug reaches the junction of the stroma and the endothelium it will again partially associate, forming the lipid-soluble moiety and thus cross the endothelium. Finally, the drug will dissociate into its water-soluble form and enter the aqueous humour. From here it can diffuse to the iris and the ciliary body which are the sites of its pharmacological action (see Fig. 42.1). Thus, the most effective penetration of the lipophilic–hydrophilic–lipophilic corneal membrane is by active ingredients having both hydrophilic and lipophilic forms. For example, highly water-soluble steroid phosphate esters have poor corneal penetration but the less water-soluble, more lipophilic steroid acetate has much better corneal penetration.




Containers for eye drops


Containers should protect the eye drops from microbial contamination, moisture and air. Container materials should not be shed or leached into solution, neither should any of the eye drop formulation be adsorbed or absorbed by the container. If the product is to be sterilized in the final container, all parts of the container must withstand the sterilization process.


Containers may be made of glass or plastic and may be single- or multiple-dose containers. The latter should not contain more than 10 mL. Both single-dose and multiple-dose packs must have tamper-evident closures and packaging.



Stay updated, free articles. Join our Telegram channel

Jun 24, 2016 | Posted by in PHARMACY | Comments Off on Ophthalmic products

Full access? Get Clinical Tree

Get Clinical Tree app for offline access